#cytokines as #biomarkers for therapeutic success in #NSCLC #nsclctrial #Immunotherapy #pd1 #pdl1 utilizing #MachineLearming , link to downloadable PDF https://bit.ly/3NTxfTt
#cytokines #biomarkers #NSCLC #nsclctrial #Immunotherapy #pd1 #pdl1 #MachineLearming
Incredibly moving to see the positive results for IMbrave050, Tecentriq+Avastin in early stage HCC. Continues to highlight the relationship between #VEGF and #PDL1 #cancer #immunotherapy #HCC @genentech @Roche https://www.gene.com/media/press-releases/14981/2023-01-18/genentechs-tecentriq-plus-avastin-is-the
#vegf #pdl1 #cancer #Immunotherapy #HCC
Beginning now. Looking forward to giving a talk of #Organoids and #PDL1 works @hkumed@twitter.com
Thanks for the invitation. Looking forward to talking about our #organoid model of immune cell development and new role of #PDL1 in #macrophage development
RT @CWu2009@twitter.com
Next week ImmuneZoom seminar #158.
This is an excellent landscape map for #cell #therapy #immunotherapy #CART #TCR #cancer. Created by Wells Fargo IG and Posted recently to LI by Basem Goueli. As noted by Jun Tang, The graphic concept originated from Vanessa Lucey from CRI and @IraMellman and I published on it for #PDL1 #PD1 in Nature in 2018 as part of the Immune set point manuscript. Incredible how the field has developed over the last several years.
#cell #therapy #Immunotherapy #cart #TCR #cancer #pdl1 #pd1